Browsing by author "Sanz Cameno, Paloma"

Repository

How to publish

Resources

FAQs

Now showing items 1-4 of 4

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome

Vidal Castiñeira, José Ramón; López Vázquez, Antonio; Martínez Borra, Jesús; Martínez Camblor, Pablo; Prieto, Jesús; López-Rodríguez, Rosario; Sanz Cameno, Paloma; Vega, J. de la; Rodrigo Sáez, Luis Ricardo; Pérez López, Rosa; Pérez Álvarez, Ramón; López Larrea, Carlos (2014)
Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection

Vidal Castiñeira, José Ramón; López Vázquez, Antonio; Díaz Bulnes, Paula; Díaz Coto, Susana; Márquez Kisinousky, L.; Martínez Borra, Jesús; Álvarez Navascués, Carmen; Sanz Cameno, Paloma; Vega, J. de la; Astudillo González, María Aurora; Rodríguez García, Manuel; López Larrea, Carlos (2020)
Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy

Hernández Bartolomé, Ángel; Borque, María J.; Rodríguez Muñoz, Yolanda; Martín Vílchez, Samuel; Trapero Marugán, María; García Buey, Luisa Consuelo; Muñoz de Rueda, Paloma; Rodrigo Sáez, Luis Ricardo; Vidal Castiñeira, José Ramón; Salmerón, Javier; Moreno Otero, Ricardo; Sanz Cameno, Paloma; López-Rodríguez, Rosario (2013)
A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping

Vidal Castiñeira, José Ramón; López Vázquez, Antonio; Alonso Arias, Rebeca; Moro García, Marco Antonio; Martínez Camblor, Pablo; Melón García, Santiago; Prieto, Jesús; López-Rodríguez, Rosario; Sanz Cameno, Paloma; Rodrigo Sáez, Luis Ricardo; Pérez López, Rosa; Pérez Álvarez, Ramón; López Larrea, Carlos (Elsevier, 2012)

Browsing by author "Sanz Cameno, Paloma"

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome ﻿

Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection ﻿

Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy ﻿

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping ﻿

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome

Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection

Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping